Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.79 USD | -45.52% | -48.37% | +14.16% |
May. 14 | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
May. 09 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Celebi
CEO | Chief Executive Officer | 52 | 18-01-31 |
Erin Colgan
DFI | Director of Finance/CFO | 43 | 20-06-30 |
Chief Tech/Sci/R&D Officer | 51 | 19-08-31 | |
Alice Drumheller
CTO | Chief Tech/Sci/R&D Officer | - | 18-07-31 |
Michael Biega
IRC | Investor Relations Contact | - | 22-05-31 |
Stephanie Krebs
PRN | Corporate Officer/Principal | - | Oct. 31 |
General Counsel | - | 22-06-30 | |
Bao Le
LAW | General Counsel | - | 21-05-31 |
Corporate Officer/Principal | 44 | 22-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Ringo
CHM | Chairman | 78 | 22-03-07 |
John Celebi
CEO | Chief Executive Officer | 52 | 18-01-31 |
Bob Holmen
BRD | Director/Board Member | 60 | 16-12-31 |
Thomas Ricks
BRD | Director/Board Member | 70 | 14-12-31 |
Deneen Vojta
BRD | Director/Board Member | 59 | 20-01-28 |
James Peyer
BRD | Director/Board Member | 37 | 19-12-31 |
Kristian Humer
BRD | Director/Board Member | 49 | 21-07-29 |
Jessie English
BRD | Director/Board Member | 60 | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,080,958 | 16,431,831 ( 65.52 %) | 0 | 65.52 % |
Company contact information
Sensei Biotherapeutics, Inc.
1405 Research Boulevard` Suite 125
20850, Rockville
+240 243 8000
http://senseibio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.16% | 19.81M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- SNSE Stock
- Company Sensei Biotherapeutics, Inc.